Evidence map›Paper›PMID 34323217›Full record

ArticleeLife2021

Murine muscle stem cell response to perturbations of the neuromuscular junction are attenuated with aging.

Jacqueline A Larouche, Mahir Mohiuddin, Jeongmoon J Choi, Peter J Ulintz, Paula Fraczek, Kaitlyn Sabin, Sethuramasundaram Pitchiaya, Sarah J Kurpiers, Jesus Castor-Macias, Wenxuan Liu and 11 more

Abstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Reactive oxygen species in the pathogenesis of sarcopenia.Free radical biology & medicine · 2025
    Review
  13. Article
  14. Article
  15. Mechanisms of the NADFrontiers in cell and developmental biology · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Jacqueline A Larouche *Department of Biomedical Engineering, University of Michigan, Ann Arbor, United States.ORCID 0000-0001-9380-3547
Mahir Mohiuddin *Parker H. Petit Institute of Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, United States.
Jeongmoon J Choi *Parker H. Petit Institute of Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, United States.
Peter J UlintzDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, United States.ORCID 0000-0002-2037-8655
Paula FraczekDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, United States.
Kaitlyn SabinDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, United States.
Sethuramasundaram PitchiayaMichigan Center for Translational Pathology, University of Michigan, Ann Arbor, United States.
Sarah J KurpiersDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, United States.
Jesus Castor-MaciasDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, United States.
Wenxuan LiuDepartment of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, United States.
Robert Louis HastingsDepartmentof Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, United States.
Lemuel A BrownDepartment of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, United States.
James F MarkworthDepartment of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, United States.
Kanishka De SilvaDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, United States.
Benjamin LeviDepartment of Surgery, University of Texas Southwestern, Dallas, United States.
Sofia D MerajverDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, United States.
Gregorio ValdezDepartmentof Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, United States.ORCID 0000-0002-0375-4532
Joe V ChakkalakalDepartment of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, United States.ORCID 0000-0002-8440-7312
Young C JangParker H. Petit Institute of Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, United States.ORCID 0000-0002-9489-2104
Susan V BrooksDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, United States.
Carlos A AguilarDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, United States.ORCID 0000-0003-3830-0634

Funding

Research Education CoreP30AG024824 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Neil Alexander · 2004 to 2026
$29.2M
PROJECT 3: Neuromuscular redox homeostasis in mice lacking SOD1 and aging wild type mice subcontract at University of LiverpoolP01AG051442 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI JACKSON, MALCOLM JOSEPH · 2016 to 2020
$8.9M
Structure, Composition, & Histology Core - Core BP30AR069620 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KARL J JEPSEN · 2016 to 2026
$8.4M
University of Michigan Postbaccalaureate Research Education Program (UM PREP)R25GM086262 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALLEN, BENJAMIN · 2009 to 2024
$6.1M
Predoctoral Training in the Molecular Biology of AgingT32AG041688 · NIA · BROWN UNIVERSITY · PI NICOLA NERETTI, John M Sedivy · 2012 to 2026
$3.5M
Interrelationships between age-related skeletal muscle stem cell and NMJ declineR01AG051456 · NIA · UNIVERSITY OF ROCHESTER · PI CHAKKALAKAL, JOE · 2015 to 2019
$1.9M
Targeting Molecular and Cellular Mediators of Inflammation to Prevent Pathologic Cell Differentiation and Heterotopic OssificationR01AR071379 · NIAMS · UT SOUTHWESTERN MEDICAL CENTER · PI LEVI, BENJAMIN · 2017 to 2021
$1.5M
Neutrophil Biomarker and neutrophil targeted therapy to predict and prevent heterotopic ossificationR61AR078072 · NIAMS · UT SOUTHWESTERN MEDICAL CENTER · PI LEVI, BENJAMIN · 2020 to 2021
$786k
Neutrophil Biomarker and neutrophil targeted therapy to predict and prevent heterotopic ossificationR33AR078072 · NIAMS · UT SOUTHWESTERN MEDICAL CENTER · PI LEVI, BENJAMIN · 2023 to 2023
$410k
NIAMS NIH HHS P30 AR069620NIAMS NIH HHS R01 AR071379NIAMS NIH HHS R33 AR078072NIAMS NIH HHS R61 AR078072NIA NIH HHS P01 AG051442NIA NIH HHS P30 AG024824NIA NIH HHS R01 AG051456NIA NIH HHS T32 AG041688NIGMS NIH HHS R25 GM086262
6 · The paper itself

Abstract

During aging and neuromuscular diseases, there is a progressive loss of skeletal muscle volume and function impacting mobility and quality of life. Muscle loss is often associated with denervation and a loss of resident muscle stem cells (satellite cells or MuSCs); however, the relationship between MuSCs and innervation has not been established. Herein, we administered severe neuromuscular trauma to a transgenic murine model that permits MuSC lineage tracing. We show that a subset of MuSCs specifically engraft in a position proximal to the neuromuscular junction (NMJ), the synapse between myofibers and motor neurons, in healthy young adult muscles. In aging and in a mouse model of neuromuscular degeneration (Cu/Zn superoxide dismutase knockout -

Indexed as

AgingAnimalsFemaleMaleMiceMice, KnockoutMuscle, SkeletalMyoblasts, SkeletalNeuromuscular JunctionSuperoxide Dismutase-1Sod1 protein, mouseSuperoxide Dismutase-1agingmouseneuromuscular junctionregenerative medicinesingle cell RNA-seqstem cellssynapse

Identifiers

PMID34323217
PMCPMC8360658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.